Alembic Pharmaceuticals rallied 4.43% to Rs 915.25 after the company said that it has received a tentative approval from US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) for Bosutinib tablets.
![Alembic Pharma spurts on USFDA nod for leukemia drug](https://img.easybranches.com/uploads/news/2024/07/alembic-pharma-spurts-on-usfda-nod-for-leukemia-drug.jpg)
Related
Share this page
Guest Posts by Easy BranchesGet Reliable Matka Guessing Forum with our Satta Matka Expert and Get all Matka Chart For Free.